Identification of common gene networks responsive to mild hyperthermia in human cancer cells

International Journal of Molecular Medicine

Volumn 32, Issue 1, 2013, Pages 195-202

  Kariya, Ayako ^a   Tabuchi, Yoshiaki ^a   Yunoki, Tatsuya ^a   Kondo, Takashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cancer cells; Gene network; Microarray; Mild hyperthermia

Indexed keywords

BCL2 ASSOCIATED ATHANOGENE 3; EARLY GROWTH RESPONSE FACTOR 1; ENDOTHELIN; HEAT SHOCK PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; CELL VIABILITY; GENE EXPRESSION; GENE IDENTIFICATION; GENE REGULATORY NETWORK; HELA CELL; HUMAN; HUMAN CELL; HYPERTHERMIA; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA;

CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84878264505     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1366     Document Type: Article

References (58)

1. Hall EJ: Hyperthermia. In: Radiobiology for the Radiologist. 5th edition. Hall EJ (ed.). Lippincott Williams & Wilkins, pp495-520, 2000.
2. Dewey WC: Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 25: 3-20, 2009.
3. van der Zee J, González González D, van Rhoon GC, van Dijk JD, van Putten WL and Hart AA: Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355: 1119-1125, 2000. (Pubitemid 30172932)
4. Wust P, Hildebrandt B, Sreenivasa G, et al: Hyperthermia in combined treatment of cancer. Lancet Oncol 3: 487-497, 2002. (Pubitemid 34863670)
5. Issels RD: Hyperthermia adds to chemotherapy. Eur J Cancer 44: 2546-2554, 2008.
6. Issels RD, Lindner LH, Verweij J, et al: Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11: 561-570, 2010.
7. Westermann A, Mella O, Van Der Zee J, et al: Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update. Int J Hyperthermia 28: 549-553, 2012.
8. Beachy SH, Repasky EA: Toward establishment of temperature thresholds for immunological impact of heat exposure in humans. Int J Hyperthermia 27: 344-352, 2011.
9. Frey B, Weiss EM, Rubner Y, et al: Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 28: 528-542, 2012.
10. Lindquist S: The heat-shock response. Annu Rev Biochem 55: 1151-1191, 1986.
11. Richter K, Haslbeck M and Buchner J: The heat shock response: life on the verge of death. Mol Cell 40: 253-266, 2010.
12. Beere HM: 'The stress of dying': the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 117: 2641-2651, 2004.
13. Li GC and Werb Z: Correlation between synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proc Natl Acad Sci USA 79: 3218-3222, 1982.
14. Nollen EA, Brunsting JF, Roelofsen H, Weber LA and Kampinga HH: In vivo chaperone activity of heat shock protein 70 and thermotolerance. Mol Cell Biol 19: 2069-2079, 1999. (Pubitemid 29098265)
15. Dinh HK, Zhao B, Schuschereba ST, Merrill G and Bowman PD: Gene expression profiling of the response to thermal injury in human cells. Physiol Genomics 7: 3-13, 2001.
16. Sonna LA, Gaffin SL, Pratt RE, Cullivan ML, Angel KC and Lilly CM: Effect of acute heat shock on gene expression by human peripheral blood mononuclear cells. J Appl Physiol 92: 2208-2220, 2002. (Pubitemid 34666453)
17. Murray JI, Whitfield ML, Trinklein ND, Myers RM, Brown PO and Botstein D: Diverse and specific gene expression responses to stresses in cultured human cells. Mol Biol Cell 15: 2361-2374, 2004. (Pubitemid 38580652)
18. Zhou M, Zhang A, Lin B, Liu J and Xu LX: Study of heat shock response of human umbilical vein endothelial cells (HUVECs) using cDNA microarray. Int J Hyperthermia 23: 225-258, 2007. (Pubitemid 46860592)
19. Wong HR, Odoms K and Sakthivel B: Divergence of canonical danger signals: the genome-level expression patterns of human mononuclear cells subjected to heat shock or lipopolysaccharide. BMC Immunol 9: 24, 2008.
20. Narita N, Noda I, Ohtsubo T, et al: Analysis of heat-shock related gene expression in head-and-neck cancer using cDNA arrays. Int J Radiat Oncol Biol Phys 53: 190-196, 2002. (Pubitemid 34465824)
21. Kato N, Kobayashi T and Honda H: Screening of stress enhancer based on analysis of gene expression profiles: enhancement of hyperthermia-induced tumor necrosis by an MMP-3 inhibitor. Cancer Sci 94: 644-649, 2003. (Pubitemid 36975022)
22. Borkamo ED, Dahl O, Bruland O and Fluge O: Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. Int J Hyperthermia 24: 425-441, 2008.
23. Laramie JM, Chung TP, Brownstein B, Stormo GD and Cobb JP: Transcriptional profiles of human epithelial cells in response to heat: computational evidence for novel heat shock proteins. Shock 29: 623-630, 2008. (Pubitemid 351559527)
24. Tabuchi Y, Takasaki I, Wada S, et al: Genes and genetic networks responsive to mild hyperthermia in human lymphoma U937 cells. Int J Hyperthermia 24: 613-622, 2008.
25. Furusawa Y, Tabuchi Y, Wada S, Takasaki I, Ohtsuka K and Kondo T: Identification of biological functions and gene networks regulated by heat stress in U937 human lymphoma cells. Int J Mol Med 28: 143-151, 2011.
26. Tabuchi Y, Wada S, Furusawa Y, Ohtsuka K and Kondo T: Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells. Int J Mol Med 29: 380-386, 2012.
27. Tabuchi Y, Furusawa Y, Kariya A, Wada S, Ohtsuka K and Kondo T: Common gene expression patterns responsive to mild temperature hyperthermia in normal human fibroblastic cells. Int J Hyperthermia 29: 38-50, 2013.
28. Furusawa Y, Iizumi T, Fujiwara Y, et al: Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress. Apoptosis 17: 102-112, 2012.
29. Tabuchi Y, Takasaki I, Doi T, Ishii Y, Sakai H and Kondo T: Genetic networks responsive to sodium butyrate in colonic epithelial cells. FEBS Lett 580: 3035-3041, 2006. (Pubitemid 43729677)
30. Ahmed K, Furusawa Y, Tabuchi Y, et al: Chemical inducers of heat shock proteins derived from medicinal plants and cytoprotective genes response. Int J Hyperthermia 28: 1-8, 2012.
31. Mariner PD, Walters RD, Espinoza CA, et al: Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 29: 499-509, 2008. (Pubitemid 351282533)
32. Spriggs KA, Bushell M and Willis AE: Translational regulation of gene expression during conditions of cell stress. Mol Cell 40: 228-237, 2010.
33. Zhou H, Li SH and Li XJ: Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation. J Biol Chem 276: 48417-48424, 2001.
34. Hageman J, van Waarde MA, Zylicz A, Walerych D and Kampinga HH: The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem J 435: 127-142, 2011.
35. Lee YJ, Lee DH, Cho CK, et al: HSP25 inhibits radiation-induced apoptosis through reduction of PKCdelta-mediated ROS production. Oncogene 24: 3715-3725, 2005.
36. Yamagishi N, Goto K, Nakagawa S, Saito Y and Hatayama T: Hsp105 reduces the protein aggregation and cytotoxicity by expanded-polyglutamine proteins through the induction of Hsp70. Exp Cell Res 316: 2424-2433, 2010.
37. Rosati A, Ammirante M, Gentilella A, et al: Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol 39: 1337-1342, 2007. (Pubitemid 47031037)
38. Jacobs AT and Marnett LJ: HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem 284: 9176-9183, 2009.
39. Behrends C, Sowa ME, Gygi SP and Harper JW: Network organization of the human autophagy system. Nature 466: 68-76, 2010.
40. Kumagai T, Miki T, Kikuchi M, et al: The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells. Oncogene 18: 467-475, 1999. (Pubitemid 29060622)
41. Chen S, Guttridge DC, Tang E, Shi S, Guan K and Wang CY: Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling. J Biol Chem 276: 39259-39263, 2001.
42. Wang MY, Chen PS, Prakash E, et al: Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res 69: 3482-3491, 2009.
43. Raymond MN, Bole-Feysot C, Banno Y, Tanfin Z and Robin P: Endothelin-1 inhibits apoptosis through a sphingosine kinase 1-dependent mechanism in uterine leiomyoma ELT3 cells. Endocrinology 147: 5873-5882, 2006. (Pubitemid 44833504)
44. Weisz L, Zalcenstein A, Stambolsky P, et al: Transactivation of the EGR1 gene contributes to mutant p53 gain of function. Cancer Res 64: 8318-8327, 2004. (Pubitemid 39491770)
45. Lüscher B: Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 277: 1-14, 2001.
46. Puhr M, Santer FR, Neuwirt H, et al: Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways. Cancer Res 69: 7375-7384, 2009.
47. Bruneau BG, Piazza LA and de Bold AJ: BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 273: H2678-H2686, 1997.
48. Koitabashi N, Arai M, Kogure S, et al: Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 49: 1120-1127, 2007. (Pubitemid 351664300)
49. Chang HH, Huang YM, Wu CP, et al: Endothelin-1 stimulates suppressor of cytokine signaling-3 gene expression in adipocytes. Gen Comp Endocrinol 178: 450-458, 2012.
50. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED and Mercola D: Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes. J Biol Chem 278: 11802-11810, 2003. (Pubitemid 36800149)
51. Maeda S: An impact of CCN2-BMP-2 complex upon chondrocyte biology: evoking a signalling pathway bypasses ERK and Smads?. J Biochem 150: 219-221, 2011.
52. Morimoto RI: Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12: 3788-3796, 1998.
53. Akerfelt M, Morimoto RI and Sistonen L: Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 11: 545-555, 2010.
54. Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC and Pascale M: Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol 215: 575-577, 2008. (Pubitemid 351632677)
55. Rossi A, Ciafrè S, Balsamo M, Pierimarchi P and Santoro MG: Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res 66: 7678-7685, 2006. (Pubitemid 44289226)
56. Nakamura Y, Fujimoto M, Hayashida N, Takii R, Nakai A and Muto M: Silencing HSF1 by short hairpin RNA decreases cell proliferation and enhances sensitivity to hyperthermia in human melanoma cell lines. J Dermatol Sci 60: 187-192, 2010.
57. Tabuchi Y, Furusawa Y, Wada S, Ohtsuka K and Kondo T: Silencing heat shock transcription factor 1 using small interfering RNA enhances mild hyperthermia and hyperthermia sensitivity in human oral squamous cell carcinoma cells. Thermal Med 27: 99-108, 2011.
58. Gabai VL, Budagova KR and Sherman MY: Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 24: 3328-3338, 2005. (Pubitemid 40695114)